|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash Flows From Operating Activities | |||||
| Net income | |||||
| Adjustments to reconcile net income to cash provided by operating activities: | |||||
| Depreciation | |||||
| Amortization of other intangible assets | |||||
| Amortization of tax credit investments | |||||
| Net (discount accretion) premium amortization | |||||
| Accretion income related to acquired loans | |||||
| Share-based compensation expense | |||||
| Provision for credit losses | |||||
| Debt securities (gains) losses, net | |||||
| Gain on sale of Visa Class B restricted shares | |||||
| Net (gains) losses on sales of loans and other assets | |||||
| Increase in cash surrender value of company-owned life insurance | |||||
| Residential real estate loans originated for sale | |||||
| Proceeds from sales of residential real estate loans | |||||
| (Increase) decrease in interest receivable | |||||
| (Increase) decrease in other assets | |||||
| Increase (decrease) in accrued expenses and other liabilities | |||||
| Net cash flows provided by (used in) operating activities | |||||
| Cash Flows From Investing Activities | |||||
| Cash received from merger, net | |||||
| Sale of health savings accounts | |||||
| Purchases of investment securities available-for-sale | |||||
| Purchases of investment securities held-to-maturity | |||||
| Purchases of Federal Home Loan Bank/Federal Reserve Bank stock | |||||
| Purchases of equity securities | |||||
| Proceeds from maturities, prepayments, and calls of investment securities available-for-sale | |||||
| Proceeds from sales of investment securities available-for-sale | |||||
| Proceeds from maturities, prepayments, and calls of investment securities held-to-maturity | |||||
| Proceeds from sales of Federal Home Loan Bank/Federal Reserve Bank stock | |||||
| Proceeds from sales of equity securities | |||||
| Loan originations and payments, net | |||||
| Proceeds from sales of commercial loans | |||||
| Proceeds from company-owned life insurance death benefits | |||||
| Proceeds from sale of premises and equipment and other assets | |||||
| Purchases of premises and equipment and other assets | |||||
| Net cash flows provided by (used in) investing activities | |||||
| Cash Flows From Financing Activities | |||||
| Net increase (decrease) in: | |||||
| Deposits | |||||
| Federal funds purchased and interbank borrowings | |||||
| Securities sold under agreements to repurchase | |||||
| Other borrowings | |||||
| Payments for maturities of Federal Home Loan Bank advances | |||||
| Payments for modification of Federal Home Loan Bank advances | |||||
| Proceeds from Federal Home Loan Bank advances | |||||
| Cash dividends paid | |||||
| Common stock repurchased | |||||
| Common stock issued for ESPP | |||||
| Common stock issued for forward sale agreements | |||||
| Net cash flows provided by (used in) financing activities | |||||
| Net increase (decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of period | |||||
| Cash and cash equivalents at end of period | |||||
Loading...
